Improving treatment for empyema in older patients
Enhanced Delivery of Thrombolytic Carriers for Empyema
['FUNDING_R01'] · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · NIH-10881730
This study is looking for better and safer ways to treat empyema in older adults by using new therapies that can help dissolve the fluid without needing surgery, making it easier for those who might have other health problems.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH CTR AT TYLER (nih funded) |
| Locations | 1 site (TYLER, UNITED STATES) |
| Trial ID | NIH-10881730 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the delivery of thrombolytic therapies for empyema, a condition that can be particularly severe in patients over 65 years old. The study aims to develop more effective and safer forms of intrapleural fibrinolytic therapy (IPFT) that can be used instead of invasive surgical options, which may not be suitable for many elderly patients with other health issues. By using advanced techniques such as ultrasound and specialized liposomal carriers, the research seeks to improve treatment outcomes and reduce complications like bleeding. The approach involves testing new therapies in a validated animal model to ensure their effectiveness before considering human trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients aged 65 and older who are diagnosed with empyema and may not be suitable for surgical intervention.
Not a fit: Patients with empyema who are younger than 65 or those who are not experiencing significant health issues may not benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective treatments for empyema, significantly improving recovery rates and quality of life for older patients.
How similar studies have performed: Previous research has shown promise in using advanced delivery systems for thrombolytic therapies, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
TYLER, UNITED STATES
- UNIVERSITY OF TEXAS HLTH CTR AT TYLER — TYLER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KOMISSAROV, ANDREY — UNIVERSITY OF TEXAS HLTH CTR AT TYLER
- Study coordinator: KOMISSAROV, ANDREY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.